mitoxantrone has been researched along with Aplasia Pure Red Cell in 2 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cervigón, I | 1 |
| Palomo, A | 1 |
| Torres-Iglesias, LM | 1 |
| Solano, F | 1 |
| Zapata, AM | 1 |
| Au, WY | 1 |
| Lam, CC | 1 |
| Chim, CS | 1 |
| Pang, AW | 1 |
| Kwong, YL | 1 |
1 review available for mitoxantrone and Aplasia Pure Red Cell
| Article | Year |
|---|---|
[Specific palatal infiltration in B-cell chronic lymphocytic leukemia].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Alkylating; Antineoplastic Combined C | 2011 |
1 other study available for mitoxantrone and Aplasia Pure Red Cell
| Article | Year |
|---|---|
Alemtuzumab induced complete remission of therapy-resistant pure red cell aplasia.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; | 2005 |